Send the following on WhatsApp
Continue to Chathttps://it.marketscreener.com/quotazioni/azione/PERSEUS-PROTEOMICS-INC-103499488/attualita/Perseus-Proteomics-Inc-presenta-alla-PMDA-la-notifica-di-sperimentazione-clinica-di-fase-I-II-su-pa-43261666/?utm_source=whatsapp&utm_medium=social&utm_campaign=share